Antibiotic treatment of Lyme borreliosis: what is the evidence?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15769910.
- Also identified by PMC identifier 1755466.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antibiotic treatment of all disease manifestations after infection with Borrelia sensu lato spp aims at resolving the presenting disease manifestation and preventing late stage disease. The goals are resolution of the preventing manifestation and prevention of the spread of bacteria to prevent late disease like arthritis. Different borrelial species prevail in Europe. The natural disease course of European borreliosis is not well defined and the effect of antibiotic treatment is unclear.
Medical subject headings
- Anti-Bacterial Agents
- Lyme Disease